Clinical Trials : Hereditary Angioedema Types I and II

Active, not recruiting

Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2014-12-10
Interventions: Biological: C1-esterase inhibitor

Completed

Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2013-07-29
Interventions:

Biological: Low-volume C1-esterase inhibitor

Recruiting

Study Name: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2013-04-04
Interventions: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc

Completed

Study Name: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor
Condition: Hereditary Angioedema Types I and II
Date: 2012-12-24
Interventions:

Biological: Berinert Berinert

Completed

Study Name: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
Condition: Hereditary Angioedema Types I and II
Date: 2012-04-10
Interventions:

Biological: C1-esterase inhibitor - single intravenous dose

Completed

Study Name: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
Condition: Hereditary Angioedema Types I and II
Date: 2011-11-07
Interventions: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection

Completed

Study Name: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
Condition:

Hereditary Angioedema Type I
Angioneurotic Edema

Date: 2005-07-04
Interventions: Drug: C1 inhibitor concentrate

Search for Clinical Trial Results

Hereditary Angioedema Types I and II - 7 Studies Found

Status	Study
Active, not recruiting	Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2014-12-10 Interventions: Biological: C1-esterase inhibitor
Completed	Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-07-29 Interventions: Biological: Low-volume C1-esterase inhibitor
Recruiting	Study Name: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-04-04 Interventions: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc
Completed	Study Name: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor Condition: Hereditary Angioedema Types I and II Date: 2012-12-24 Interventions: Biological: Berinert Berinert
Completed	Study Name: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route Condition: Hereditary Angioedema Types I and II Date: 2012-04-10 Interventions: Biological: C1-esterase inhibitor - single intravenous dose
Completed	Study Name: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert Condition: Hereditary Angioedema Types I and II Date: 2011-11-07 Interventions: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection
Completed	Study Name: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N Condition: Hereditary Angioedema Type I Angioneurotic Edema Date: 2005-07-04 Interventions: Drug: C1 inhibitor concentrate